EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access

Red Blood Cell Transfusion in European Neonatal Intensive Care Units, 2022 to 2023

Nina A M Houben, Suzanne Fustolo-Gunnink, Karin Fijnvandraat, Camila Caram-Deelder, Marta Aguar Carrascosa, Alain Beuchée, Kristin Brække, Francesco Cardona, Anne Debeer, Sara Domingues, Stefano Ghirardello, Ruza Grizelj und 21 weitere

JAMA Network Open · 19.09.2024 · 7 (9) · e2434077

DOI: 10.1001/jamanetworkopen.2024.34077 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift JAMA Network Open, online erschienen am 19.09.2024. Verfasst von Nina A M Houben und 32 weiteren Autor:innen. Beteiligte Einrichtung: Sanquin Research, Sanquin Blood Supply Foundation, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Erythrocyte Transfusion, Intensive Care Units, Neonatal. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Red blood cell (RBC) transfusions are frequently administered to preterm infants born before 32 weeks of gestation in the neonatal intensive care unit (NICU). Two randomized clinical trials (Effects of Transfusion Thresholds on Neurocognitive Outcomes of Extremely Low-Birth-Weight Infants [ETTNO] and Transfusion of Prematures [TOP]) found that liberal RBC transfusion thresholds are nonsuperior to restrictive thresholds, but the extent to which these results have been integrated into clinical practice since publication in 2020 is unknown.

Objective

To describe neonatal RBC transfusion practice in Europe. Design, Setting, and Participants This international prospective observational cohort study collected data between September 1, 2022, and August 31, 2023, with a 6-week observation period per center, from 64 NICUs in 22 European countries. Participants included 1143 preterm infants born before 32 weeks of gestation. Exposure Admission to the NICU. Main Outcomes and Measures Study outcome measures included RBC transfusion prevalence rates, cumulative incidence, indications, pretransfusion hemoglobin (Hb) levels, volumes, and transfusion rates, Hb increment, and adverse effects of RBC transfusion.

Results

A total of 1143 preterm infants were included (641 male [56.1%]; median gestational age at birth, 28 weeks plus 2 days [IQR, 26 weeks plus 2 days to 30 weeks plus 2 days]; median birth weight, 1030 [IQR, 780-1350] g), of whom 396 received 1 or more RBC transfusions, totaling 903 transfusions. Overall RBC transfusion prevalence rate during postnatal days 1 to 28 was 3.4 transfusion days per 100 admission days, with considerable variation across countries, only partly explained by patient mix. By day 28, 36.5% (95% CI, 31.6%-41.5%) of infants had received at least 1 transfusion. Most transfusions were given based on a defined Hb threshold (748 [82.8%]). Hemoglobin levels before transfusions indicated for threshold were below the restrictive thresholds set by ETTNO in 324 of 729 transfusions (44.4%) and TOP in 265 of 729 (36.4%). Conversely, they were between restrictive and liberal thresholds in 352 (48.3%) and 409 (56.1%) transfusions, respectively, and above liberal thresholds in 53 (7.3%) and 55 (7.5%) transfusions, respectively. Most transfusions given based on threshold had volumes of 15 mL/kg (470 of 738 [63.7%]) and were administered over 3 hours (400 of 738 [54.2%]), but there was substantial variation in dose and duration. Conclusions and Relevance In this cohort study of very preterm infants, most transfusions indicated for threshold were given for pretransfusion Hb levels above restrictive transfusion thresholds evaluated in recent trials. These results underline the need to optimize practices and for implementation research to support uptake of evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erythrocyte TransfusionIntensive Care Units, NeonatalHumansInfant, NewbornEuropeProspective StudiesFemaleMaleInfant, Premature

Autor:innen und Institutionen

  • Sanquin Research, Sanquin Blood Supply Foundation, Amsterdam, the Netherlands.
  • Division of Neonatology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, the Netherlands.
  • Pediatric Hematology, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • Sanquin Research, Department of Molecular Cellular Hemostasis, Amsterdam, the Netherlands.
  • Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Neonatology, La Fe University Hospital, Valencia, Spain.

Zitieren

APA

Houben, N. A. M., Fustolo-Gunnink, S., Fijnvandraat, K., Caram-Deelder, C., Carrascosa, M. A., Beuchée, A., Brække, K., Cardona, F., Debeer, A., Domingues, S., Ghirardello, S., Grizelj, R., Hadžimuratovic, E., Heiring, C., Krivec, J. L., Malý, J., Matasova, K., Moore, C. M., Muehlbacher, T., …, & International Neonatal Transfusion Point Prevalence Study Group (2024). Red Blood Cell Transfusion in European Neonatal Intensive Care Units, 2022 to 2023. JAMA Network Open, 7(9), e2434077. https://doi.org/10.1001/jamanetworkopen.2024.34077

Vancouver

Houben NAM, Fustolo-Gunnink S, Fijnvandraat K, Caram-Deelder C, Carrascosa MA, Beuchée A, et al. Red Blood Cell Transfusion in European Neonatal Intensive Care Units, 2022 to 2023. JAMA Network Open. 2024;7(9):e2434077. doi:10.1001/jamanetworkopen.2024.34077

BibTeX
@article{Houben2024,
  author = {Houben, Nina A M and Fustolo-Gunnink, Suzanne and Fijnvandraat, Karin and Caram-Deelder, Camila and Carrascosa, Marta Aguar and Beuchée, Alain and Brække, Kristin and Cardona, Francesco and Debeer, Anne and Domingues, Sara and Ghirardello, Stefano and Grizelj, Ruza and Hadžimuratovic, Emina and Heiring, Christian and Krivec, Jana Lozar and Malý, Jan and Matasova, Katarina and Moore, Carmel Maria and Muehlbacher, Tobias and Szabó, Miklos and Szczapa, Tomasz and Zaharie, Gabriela and de Jager, Justine and Reibel-Georgi, Nora Johanna and New, Helen V and Stanworth, Simon J and Deschmann, Emöke and Roehr, Charles C and Dame, Christof and le Cessie, Saskia and van der Bom, Johanna and Lopriore, Enrico and International Neonatal Transfusion Point Prevalence Study Group, International Neonatal Transfusion Point Prevalence Study Group},
  title = {Red Blood Cell Transfusion in European Neonatal Intensive Care Units, 2022 to 2023},
  journal = {JAMA Network Open},
  year = {2024},
  volume = {7},
  number = {9},
  pages = {e2434077},
  doi = {10.1001/jamanetworkopen.2024.34077}
}
Kostenlos starten →